SIBIONICS Received CE Mark for Its Ground-breaking GS1 Continuous Glucose Monitoring System
On November 01, 2023, SIBIONICS, the world's third-largest Continuous Glucose Monitoring System (CGM) brand, received the CE Mark for its revolutionary GS1 CGM.
This significant milestone marks a momentous achievement for SIBIONICS, facilitating the distribution and utilization of this game-changing technology throughout the European market.
The SIBIONICS GS1 CGM offers users 14 days of calibration-free continuous glucose monitoring solution, empowering patients with the capability to transmit glucose data to their monitoring devices or mobile applications and ge...